DPP4 and respiratory tract infectious disorder: Another study using a Spanish general practice research database and a meta-analysis of randomized controlled trials (RCTs), on the other hand, showed no protective effects against pneumonia or respiratory infections with DPP-4 inhibitor use compared against active comparator drugs43,44.